Abstract

The Japanese encephalitis virus (JEV) is a leading cause of mosquito-borne viral encephalitis worldwide. Clinical symptoms other than encephalitis, on the other hand, are substantially more prevalent with JEV infection, demonstrating the relevance of peripheral pathophysiology. We studied the peripheral immunopathogenesis of JEV using IFNAR deficient (IFNAR–/–) mice infected with the SA14-14-2 strain under the BSL-2. The body weight and survival rate of infected-IFNAR–/–mice decreased significantly. Infected-IFNAR–/–mice’s liver and spleen demonstrated obvious tissue damage and inflammatory cell infiltration. There was also extensive viral replication in the organs. IFN-α/β protein expression was dramatically elevated in peripheral tissues and serum, although the related interferon-stimulated genes (ISGs) remained low in the spleen and liver of infected-IFNAR–/–animals. Consistently, the differentially expressed genes (DEGs) analysis using RNA-sequencing of spleens showed inflammatory cytokines upregulation, such as IL-6, TNF-α, and MCP-1, and IFN-γ associated cytokine storm. The infiltration of macrophages and neutrophils in the spleen and liver of SA14-14-2-infected IFNAR–/– mice was dramatically elevated. However, there was no significant difference in tissue damage, viral multiplication, or the production of IFNα/β and inflammatory cytokines in the brain. Infection with the JEV SA14-14-2 strain resulted in a lethal peripheral inflammatory response and organ damage without encephalitis in IFNAR–/– mice. Our findings may help shed light on the peripheral immunopathogenesis associated with clinical JEV infection and aid in developing treatment options.

Highlights

  • Japanese encephalitis virus (JEV), as positive single-stranded RNA virus, along with dengue virus (DENV), West Nile virus (WNV), Yellow fever virus (YFV), and Zika virus, mainly makes up of genus Flavivirus (Chambers et al, 1990; Unni et al, 2011)

  • Similar and relatively weaker clinical symptoms were observed with a dose of 5 × 105 PFU/mice, and no significant symptoms were observed with a dose of 5 × 104 PFU/mice. These results indicated that the susceptibility and lethality of IFNAR−/− mice increased dose-dependent to SA14-14-2, and IFNAR was indispensable for the attenuation of the SA14-14-2 strain in vivo

  • The clinical features of JEVinfected individuals vary from mild symptoms to severe meningitis, the risk of virus encephalitis may be low in the clinic with 1% probability (Halstead and Jacobson, 2013)

Read more

Summary

Introduction

Japanese encephalitis virus (JEV), as positive single-stranded RNA virus, along with dengue virus (DENV), West Nile virus (WNV), Yellow fever virus (YFV), and Zika virus, mainly makes up of genus Flavivirus (Chambers et al, 1990; Unni et al, 2011). JEV affects the central nervous system (CNS) and causes 50,000– 70,000 viral encephalitis cases with a high case fatality rate of 30– 50% worldwide (Ghosh and Basu, 2009; Misra and Kalita, 2010). JEV is one of the mosquito-borne flaviviruses and is transmitted by culex. After the host is bitten by a mosquito infected with JEV, the virus begins to replicate, migrates through the periphery, such as draining lymph nodes, spleen, and kidney, and even crossing the blood-brain barrier (BBB) into the CNS (King et al, 2007; Dutta and Basu, 2014). Bovine and water birds amplify host supply virus in the blood for feeding mosquitoes, and JEV infects dead-end host humans (Turtle and Solomon, 2018). Japanese encephalitis (JE) is endemic to the entire Asia-Pacific region and has recently spread to new geographical locations due to the expansion of the mosquito territory (Erlanger et al, 2009; Connor and Bunn, 2017)

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.